Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News



Format: 04/16/2014
Format: 04/16/2014


Forbes.com: Failed Avastin study detailed, other trials go on

Tuesday, June 2nd, 2009

ORLANDO, Fla., May 30 (Reuters) - A failed study of  blockbuster drug Avastin in colon cancer patients who have

 was detailed for the first time on Saturday, but similar clinical trials are still ongoing.

The 2,710-patient trial, for which top-line results were announced in April, found that adding Avastin to standard

chemotherapy did not improve disease-free survival for patients with locally advanced colon cancer.

To read more, visit Forbes.com.

West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 7 + 7 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.